IDEAS home Printed from https://ideas.repec.org/e/paa10.html
   My authors  Follow this author

Eline Aas

Personal Details

First Name:Eline
Middle Name:
Last Name:Aas
Suffix:
RePEc Short-ID:paa10
[This author has chosen not to make the email address public]

Affiliation

(50%) Helseøkonomisk Forskningsprogram (HERO)
Universitetet i Oslo

Oslo, Norway
http://www.hero.uio.no/
RePEc:edi:heuiono (more details at EDIRC)

(50%) Institutt for Helseledelse og Helseökonomi
Universitetet i Oslo

Oslo, Norway
http://www.med.uio.no/heled/
RePEc:edi:ihuiono (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters

Working papers

  1. Aas, Eline & Gomez, Monica & Tariq, Fawaz, 2022. "Health Technology Assessment (HTA) of GLP-1 receptor agonists and SGLT-2 inhibitors in combination with metformin as first-line treatment in patient with type 2 diabetes mellitus (T2DM) and establishe," HERO Online Working Paper Series 2022:3, University of Oslo, Health Economics Research Programme.
  2. Lurås, Hilde & Aas, Eline, 2009. "Bruk av paneldatametoder til å belyse allmennlegers henvisningsmønster," HERO Online Working Paper Series 2002:6, University of Oslo, Health Economics Research Programme.
  3. Aas, Eline, 2009. "Cost-effectiveness of screening for colorectal cancer with once-only flexible sigmoidoscopy and faecal occult blood test," HERO Online Working Paper Series 2008:6, University of Oslo, Health Economics Research Programme.
  4. Aas, Eline, 2009. "Pecuniary compensation increases the participation rate in screening for colorectal cancer," HERO Online Working Paper Series 2005:7, University of Oslo, Health Economics Research Programme.
  5. Aas, Eline, 2009. "The effect of screening on treatment cost: The case of colorectal cancer," HERO Online Working Paper Series 2008:5, University of Oslo, Health Economics Research Programme.

Articles

  1. Anna Kenseth & Dominika Kantorova & Mikyung Kelly Seo & Eline Aas & John Cairns & David Kerr & Hanne Askautrud & Jørn Evert Jacobsen, 2024. "Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?," PharmacoEconomics, Springer, vol. 42(6), pages 679-691, June.
  2. Natalia Kunst & Emily A. Burger & Veerle M. H. Coupé & Karen M. Kuntz & Eline Aas, 2024. "A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework," PharmacoEconomics, Springer, vol. 42(4), pages 363-371, April.
  3. Mathyn Vervaart & Eline Aas & Karl P. Claxton & Mark Strong & Nicky J. Welton & Torbjørn Wisløff & Anna Heath, 2023. "General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations," Medical Decision Making, , vol. 43(5), pages 595-609, July.
  4. Mathyn Vervaart & Mark Strong & Karl P. Claxton & Nicky J. Welton & Torbjørn Wisløff & Eline Aas, 2022. "An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial," Medical Decision Making, , vol. 42(5), pages 612-625, July.
  5. Annette Kjær Ersbøll & Kaushik Sengupta & Eero Pukkala & Kristian Bolin & Eline Aas & Martha Emneus & Dena Rosen Ramey & Joanne E. Brady & Daniel Mines & Kristian Aasbjerg & Christian Vestergaard & Gu, 2021. "Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015," Drug Safety, Springer, vol. 44(11), pages 1231-1242, November.
  6. Svenn Alexander Hansen & Eline Aas & Oddvar Solli, 2020. "A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 73-84, February.
  7. Paal Joranger & Arild Nesbakken & Halfdan Sorbye & Geir Hoff & Arne Oshaug & Eline Aas, 2020. "Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 321-334, April.
  8. Han-I. Wang & Alexandra Smith & Eline Aas & Eve Roman & Simon Crouch & Cathy Burton & Russell Patmore, 2017. "Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(2), pages 255-267, March.
  9. Fredrik Salvesen Haukaas & Trude Margrete Arnesen & Brita Askeland Winje & Eline Aas, 2017. "Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(4), pages 405-415, May.
  10. Tron A. Moger & Gudrun M. W. Bjørnelv & Eline Aas, 2016. "Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(6), pages 745-754, July.
  11. Paal Joranger & Arild Nesbakken & Geir Hoff & Halfdan Sorbye & Arne Oshaug & Eline Aas, 2015. "Modeling and Validating the Cost and Clinical Pathway of Colorectal Cancer," Medical Decision Making, , vol. 35(2), pages 255-265, February.
  12. Tor Iversen & Eline Aas & Gunnar Rosenqvist & Unto Häkkinen & on behalf of the EuroHOPE study group, 2015. "Comparative Analysis of Treatment Costs in EUROHOPE," Health Economics, John Wiley & Sons, Ltd., vol. 24(S2), pages 5-22, December.
  13. Eline Aas, 2009. "Pecuniary compensation increases participation in screening for colorectal cancer," Health Economics, John Wiley & Sons, Ltd., vol. 18(3), pages 337-354, March.

Chapters

  1. Eline Aas & Tor Iversen & Oddvar Kaarboe, 2021. "The Economic Sustainability of the Norwegian Healthcare System," Contributions to Economic Analysis, in: The Sustainability of Health Care Systems in Europe, volume 127, pages 81-101, Emerald Group Publishing Limited.
  2. Eline Aas & Tor Iversen & Geir Hoff, 2017. "The Effect of Education on Health Behavior after Screening for Colorectal Cancer," Advances in Health Economics and Health Services Research, in: Human Capital and Health Behavior, volume 25, pages 207-242, Emerald Group Publishing Limited.
  3. Eline Aas, 2014. "Chapter 10: Policy Implications," World Scientific Book Chapters, in: Sherman Folland & Lorenzo Rocco (ed.), The Economics of Social Capital and Health A Conceptual and Empirical Roadmap, chapter 10, pages 203-217, World Scientific Publishing Co. Pte. Ltd..

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Aas, Eline, 2009. "Cost-effectiveness of screening for colorectal cancer with once-only flexible sigmoidoscopy and faecal occult blood test," HERO Online Working Paper Series 2008:6, University of Oslo, Health Economics Research Programme.

    Cited by:

    1. Paal Joranger & Arild Nesbakken & Halfdan Sorbye & Geir Hoff & Arne Oshaug & Eline Aas, 2020. "Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 321-334, April.
    2. Paal Joranger & Arild Nesbakken & Geir Hoff & Halfdan Sorbye & Arne Oshaug & Eline Aas, 2015. "Modeling and Validating the Cost and Clinical Pathway of Colorectal Cancer," Medical Decision Making, , vol. 35(2), pages 255-265, February.

  2. Aas, Eline, 2009. "Pecuniary compensation increases the participation rate in screening for colorectal cancer," HERO Online Working Paper Series 2005:7, University of Oslo, Health Economics Research Programme.

    Cited by:

    1. Franz Hackl & Martin Halla & Michael Hummer & Gerald J. Pruckner, 2012. "The Effectiveness of Health Screening," NRN working papers 2012-01, The Austrian Center for Labor Economics and the Analysis of the Welfare State, Johannes Kepler University Linz, Austria.
    2. You, Kai, 2011. "Education, risk perceptions, and health behaviors," MPRA Paper 35535, University Library of Munich, Germany.
    3. Nadine Chami & Arthur Sweetman, 2019. "Payment models in primary health care: A driver of the quantity and quality of medical laboratory utilization," Health Economics, John Wiley & Sons, Ltd., vol. 28(10), pages 1166-1178, October.

Articles

  1. Mathyn Vervaart & Mark Strong & Karl P. Claxton & Nicky J. Welton & Torbjørn Wisløff & Eline Aas, 2022. "An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial," Medical Decision Making, , vol. 42(5), pages 612-625, July.

    Cited by:

    1. Mathyn Vervaart & Eline Aas & Karl P. Claxton & Mark Strong & Nicky J. Welton & Torbjørn Wisløff & Anna Heath, 2023. "General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations," Medical Decision Making, , vol. 43(5), pages 595-609, July.

  2. Tor Iversen & Eline Aas & Gunnar Rosenqvist & Unto Häkkinen & on behalf of the EuroHOPE study group, 2015. "Comparative Analysis of Treatment Costs in EUROHOPE," Health Economics, John Wiley & Sons, Ltd., vol. 24(S2), pages 5-22, December.

    Cited by:

    1. Baser, Onur, 2021. "Population density index and its use for distribution of Covid-19: A case study using Turkish data," Health Policy, Elsevier, vol. 125(2), pages 148-154.
    2. Richard Heijink & Peter Engelfriet & Clas Rehnberg & Sverre A. C. Kittelsen & Unto Häkkinen & on behalf of the EuroHOPE study group, 2015. "A Window on Geographic Variation in Health Care: Insights from EuroHOPE," Health Economics, John Wiley & Sons, Ltd., vol. 24(S2), pages 164-177, December.
    3. Unto Häkkinen & Tor Iversen & Mikko Peltola & Clas Rehnberg & Timo T. Seppälä & on behalf of the EuroHOPE study group, 2015. "Towards Explaining International Differences in Health Care Performance: Results of the EuroHOPE Project," Health Economics, John Wiley & Sons, Ltd., vol. 24(S2), pages 1-4, December.
    4. Unto Häkkinen & Gunnar Rosenqvist & Tor Iversen & Clas Rehnberg & Timo T. Seppälä & on behalf of the EuroHOPE study group, 2015. "Outcome, Use of Resources and Their Relationship in the Treatment of AMI, Stroke and Hip Fracture at European Hospitals," Health Economics, John Wiley & Sons, Ltd., vol. 24(S2), pages 116-139, December.
    5. Sverre A. C. Kittelsen & Kjartan S. Anthun & Fanny Goude & Ingrid M. S. Huitfeldt & Unto Häkkinen & Marie Kruse & Emma Medin & Clas Rehnberg & Hanna Rättö & on behalf of the EuroHOPE study group, 2015. "Costs and Quality at the Hospital Level in the Nordic Countries," Health Economics, John Wiley & Sons, Ltd., vol. 24(S2), pages 140-163, December.

  3. Eline Aas, 2009. "Pecuniary compensation increases participation in screening for colorectal cancer," Health Economics, John Wiley & Sons, Ltd., vol. 18(3), pages 337-354, March.

    Cited by:

    1. Franz Hackl & Martin Halla & Michael Hummer & Gerald J. Pruckner, 2012. "The Effectiveness of Health Screening," NRN working papers 2012-01, The Austrian Center for Labor Economics and the Analysis of the Welfare State, Johannes Kepler University Linz, Austria.
    2. You, Kai, 2011. "Education, risk perceptions, and health behaviors," MPRA Paper 35535, University Library of Munich, Germany.
    3. Nadine Chami & Arthur Sweetman, 2019. "Payment models in primary health care: A driver of the quantity and quality of medical laboratory utilization," Health Economics, John Wiley & Sons, Ltd., vol. 28(10), pages 1166-1178, October.

Chapters

    Sorry, no citations of chapters recorded.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 4 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (4) 2009-06-03 2009-06-03 2009-06-03 2022-10-31
  2. NEP-LAB: Labour Economics (1) 2009-06-03

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Eline Aas should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.